Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine in Alcoholic Hepatitis
NCT00962442Phase 3Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2000
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcoholic hepatitis (AH) comparing NAC + Nutrition with Placebo + Nutrition (2 arms). Primary endpoint: Six months survival at 6 months. Started Sep 2000; status: completed.
02
Drugs
acetylcysteine
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT00962442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00962442.